scispace - formally typeset
Open AccessJournal ArticleDOI

Risk and Cumulative Risk of Stroke Recurrence A Systematic Review and Meta-Analysis

TLDR
The cumulative risk of recurrence varies greatly up to 10 years, and methodological differences are likely to play an important role and consensus on definitions would improve future comparability of estimates and characterization of groups of stroke survivors at increased risk ofRecurrence.
Abstract
Background and Purpose—Estimates of risk of stroke recurrence are widely variable and focused on the short- term. A systematic review and meta-analysis was conducted to estimate the pooled cumulative risk of stroke recurrence. Methods—Studies reporting cumulative risk of recurrence after first-ever stroke were identified using electronic databases and by manually searching relevant journals and conference abstracts. Overall cumulative risks of stroke recurrence at 30 days and 1, 5, and 10 years after first stroke were calculated, and analyses for heterogeneity were conducted. A Weibull model was fitted to the risk of stroke recurrence of the individual studies and pooled estimates were calculated with 95% CI. Results—Sixteen studies were identified, of which 13 studies reported cumulative risk of stroke recurrence in 9115 survivors. The pooled cumulative risk was 3.1% (95% CI, 1.7–4.4) at 30 days, 11.1% (95% CI, 9.0–13.3) at 1 year, 26.4% (95% CI, 20.1–32.8) at 5 years, and 39.2% (95% CI, 27.2–51.2) at 10...

read more

Citations
More filters
Journal ArticleDOI

Factors Influencing the Decline in Stroke Mortality A Statement From the American Heart Association/American Stroke Association

TL;DR: There is strong evidence that the decline in stroke mortality can be attributed to a combination of interventions and programs based on scientific findings and implemented with the purpose of reducing stroke risks, the most likely being improved control of hypertension.
Journal ArticleDOI

Inflammation in CNS neurodegenerative diseases.

TL;DR: A better understanding of neuroimmune interactions during development and disease will be key to further manipulating these responses and the development of effective therapies to improve quality of life, and reduce the impact of neuroinflammatory and degenerative diseases.
References
More filters
Journal ArticleDOI

Meta-Analysis in Clinical Trials*

TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal ArticleDOI

The Statistical Analysis of Failure Time Data

Laurence L George
- 01 Aug 2003 - 
TL;DR: This book complements the other references well, and merits a place on the bookshelf of anyone concerned with the analysis of lifetime data from any Ž eld.
Journal ArticleDOI

The statistical analysis of failure time data

TL;DR: In this article, the authors proposed a regression model for failure time distributions in the context of counting process models and showed that the model can be used to estimate the probability of failure.
Journal ArticleDOI

Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study

TL;DR: Empirical observational studies that possess wide access to appropriate diagnostic technologies and apply standardized etiologic classifications provide a much better understanding of underlying risk factors for initial stroke, recurrence, and mortality.
Related Papers (5)